Drug
Zodasiran
Zodasiran: highest development phase Phase 3, developed by Arrowhead Pharmaceuticals. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Arrowhead Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| Zodasiran NCT07473843 | Phase 3 | Homozygous Familial Hypercholesterolemia |
| zodasiran Injection NCT07037771 | Phase 3 | Homozygous Familial Hypercholesterolemia |
Latest
No recent events.
Follow Zodasiran on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.